Cargando…

HPV16 E6 upregulates Aurora A expression

Overexpression of Aurora A kinase occurs in certain types of cancer, and therefore results in chromosome instability and phosphorylation-mediated ubiquitylation and degradation of p53 for tumorigenesis. The high-risk subtype human papillomavirus (HPV)16 early oncoprotein E6 is a major contributor in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Yi, Ma, Jiaming, Zheng, Yahong, Li, Lu, Gui, Xiaowei, Wang, Qian, Meng, Xiangkai, Shang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950527/ https://www.ncbi.nlm.nih.gov/pubmed/27446442 http://dx.doi.org/10.3892/ol.2016.4786

Ejemplares similares

Human Papillomavirus 16 E6 Contributes HIF-1α Induced Warburg Effect by Attenuating the VHL-HIF-1α Interaction
por: Guo, Yi, et al.
Publicado: (2014)

The ING4 Binding with p53 and Induced p53 Acetylation were Attenuated by Human Papillomavirus 16 E6
por: Guo, Yi, et al.
Publicado: (2013)

HPV16 E6 Promotes the Progression of HPV Infection-Associated Cervical Cancer by Upregulating Glucose-6-Phosphate Dehydrogenase Expression
por: Chang, Ye-Fei, et al.
Publicado: (2021)

E6/E7 and E6(*) From HPV16 and HPV18 Upregulate IL-6 Expression Independently of p53 in Keratinocytes
por: Artaza-Irigaray, Cristina, et al.
Publicado: (2019)

HPV16 E6 Promotes Breast Cancer Proliferation via Upregulation of COX-2 Expression
por: Wang, Y. X., et al.
Publicado: (2017)

Establishment of immunoassay for detecting HPV16 E6 and E7 RNA
por: Ding, Sen, et al.
Publicado: (2015)

5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression
por: Morel, Adrien, et al.
Publicado: (2017)

The Dimeric Form of HPV16 E6 Is Crucial to Drive YAP/TAZ Upregulation through the Targeting of hScrib
por: Messa, Lorenzo, et al.
Publicado: (2021)

Fusion of CTLA-4 with HPV16 E7 and E6 Enhanced the Potency of Therapeutic HPV DNA Vaccine
por: Gan, Lili, et al.
Publicado: (2014)

In silico prediction of structural changes in human papillomavirus type 16 (HPV16) E6 oncoprotein and its variants
por: Rodríguez-Ruiz, Hugo Alberto, et al.
Publicado: (2019)

E6-Encoded by Cancer-Causing Human Papillomavirus Interacts with Aurora Kinase A To Promote HPV-Mediated Carcinogenesis
por: Li, Sile, et al.
Publicado: (2023)

HPV16 E6 seropositivity among cancer-free men with oral, anal or genital HPV16 infection
por: Beachler, Daniel C., et al.
Publicado: (2016)

Differential localization of HPV16 E6 splice products with E6-associated protein
por: Vaeteewoottacharn, Kulthida, et al.
Publicado: (2005)

HPV16 E6 and E7 Upregulate Interferon-Induced Antiviral Response Genes ISG15 and IFIT1 in Human Trophoblast Cells
por: Ambühl, Lea M. M., et al.
Publicado: (2017)

Deep Sequencing of HPV16 E6 Region Reveals Unique Mutation Pattern of HPV16 and Predicts Cervical Cancer
por: Ai, Wenchao, et al.
Publicado: (2022)

A Non-oncogenic HPV 16 E6/E7 Vaccine Enhances Treatment of HPV Expressing Tumors
por: Wieking, Bryant G., et al.
Publicado: (2012)

Augmentation of cellular and humoral immune responses to HPV16 and HPV18 E6 and E7 antigens by VGX-3100
por: Morrow, Matthew P, et al.
Publicado: (2016)

Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancers
por: Chang, J T-C, et al.
Publicado: (2010)

Gene silencing of HPV16 E6/E7 induced by promoter-targeting siRNA in SiHa cells
por: Hong, D, et al.
Publicado: (2009)

Flavonol and imidazole derivatives block HPV16 E6 activities and reactivate apoptotic pathways in HPV(+) cells
por: Yuan, C-H, et al.
Publicado: (2016)

A replicative recombinant HPV16 E7 expression virus upregulates CD36 in C33A cells
por: Shao, Yunting, et al.
Publicado: (2023)

A novel HPV16 E7-affitoxin for targeted therapy of HPV16-induced human cervical cancer
por: Jiang, Pengfei, et al.
Publicado: (2018)

Association of cervical carcinogenesis risk with HPV16 E6 and E7 variants in the Taizhou area, China
por: Dai, Mei-Zhen, et al.
Publicado: (2021)

Viral E6 is overexpressed via high viral load in invasive cervical cancer with episomal HPV16
por: Hong, Die, et al.
Publicado: (2017)

Short half‐life of HPV16 E6 and E7 mRNAs sensitizes HPV16‐positive tonsillar cancer cell line HN26 to DNA‐damaging drugs
por: Wu, Chengjun, et al.
Publicado: (2018)

Diversity of cervicovaginal human papillomavirus (HPV) genotypes and naturally occurring E6/E7 DNA polymorphisms of HPV-16 in Ghana
por: Kaba, Gladys, et al.
Publicado: (2023)

HPV16 E6/E7 -based mRNA vaccine is therapeutic in mice bearing aggressive HPV-positive lesions
por: Zhou, Kun, et al.
Publicado: (2023)

Human papillomavirus16 E6 but not E7 upregulates GLUT1 expression in lung cancer cells by upregulating thioredoxin expression
por: Gao, Zi-Yu, et al.
Publicado: (2021)

Comparative RNA sequencing reveals that HPV16 E6 abrogates the effect of E6*I on ROS metabolism
por: Paget-Bailly, Philippe, et al.
Publicado: (2019)

Effects of HPV16E6 transfection on the biological behavior of Eca109 and Eca9706 cells
por: Kang, Xin-Dan, et al.
Publicado: (2018)

Effects of HPV16E6 transfection on the biological behavior of Eca109 and Eca9706 cells
por: Kang, Xin-Dan, et al.
Publicado: (2021)

MiR-375 Is Epigenetically Downregulated by HPV-16 E6 Mediated DNMT1 Upregulation and Modulates EMT of Cervical Cancer Cells by Suppressing lncRNA MALAT1
por: Liu, Shikai, et al.
Publicado: (2016)

KSHV co-infection down-regulates HPV16 E6 and E7 from cervical cancer cells
por: Dai, Lu, et al.
Publicado: (2017)

An RNA Aptamer Targets the PDZ-Binding Motif of the HPV16 E6 Oncoprotein
por: Belyaeva, Tamara A., et al.
Publicado: (2014)

HPV16 E6 seropositivity and oropharyngeal cancer: Marker of exposure, risk, or disease?
por: Landy, Rebecca, et al.
Publicado: (2021)

Phylogeny and polymorphism in the E6 and E7 of human papillomavirus: alpha-9 (HPV16, 31, 33, 52, 58), alpha-5 (HPV51), alpha-6 (HPV53, 66), alpha-7 (HPV18, 39, 59, 68) and alpha-10 (HPV6, 44) in women from Shanghai
por: Zhao, Junwei, et al.
Publicado: (2019)

Disruption of HPV16-E7 by CRISPR/Cas System Induces Apoptosis and Growth Inhibition in HPV16 Positive Human Cervical Cancer Cells
por: Hu, Zheng, et al.
Publicado: (2014)

Development and validation of a multiplex qPCR assay for detection and relative quantification of HPV16 and HPV18 E6 and E7 oncogenes
por: Bordigoni, Alexia, et al.
Publicado: (2021)

The HPV16 E6 binding protein Tip-1 interacts with ARHGEF16, which activates Cdc42
por: Oliver, A W, et al.
Publicado: (2011)

Sequential Cisplatin Therapy and Vaccination with HPV16 E6E7L2 Fusion Protein in Saponin Adjuvant GPI-0100 for the Treatment of a Model HPV16+ Cancer
por: Peng, Shiwen, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_q796h6dmvbipsj1s51e1una478